Yuichi Nozaki

5.6k total citations
78 papers, 3.2k citations indexed

About

Yuichi Nozaki is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Yuichi Nozaki has authored 78 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 21 papers in Surgery and 17 papers in Hepatology. Recurrent topics in Yuichi Nozaki's work include Liver Disease Diagnosis and Treatment (42 papers), Diet, Metabolism, and Disease (11 papers) and Metabolism, Diabetes, and Cancer (9 papers). Yuichi Nozaki is often cited by papers focused on Liver Disease Diagnosis and Treatment (42 papers), Diet, Metabolism, and Disease (11 papers) and Metabolism, Diabetes, and Cancer (9 papers). Yuichi Nozaki collaborates with scholars based in Japan, United States and Italy. Yuichi Nozaki's co-authors include Atsushi Nakajima, Masato Yoneda, Koji Fujita, Satoru Saito, Hiroyuki Kirikoshi, Masahiko Inamori, Hirokazu Takahashi, Kensuke Kubota, Hironori Mawatari and Kunihiro Hosono and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Gastroenterology.

In The Last Decade

Yuichi Nozaki

71 papers receiving 3.2k citations

Peers

Yuichi Nozaki
Narci Teoh Australia
Marica Meroni Italy
Masafumi Ono Japan
Roberto Torella Italy
Lihua Zhu China
Janki Patel United States
Chandrashekhar R. Gandhi United States
Ting Qian China
Karim Gariani Switzerland
Hiroki Endo Japan
Narci Teoh Australia
Yuichi Nozaki
Citations per year, relative to Yuichi Nozaki Yuichi Nozaki (= 1×) peers Narci Teoh

Countries citing papers authored by Yuichi Nozaki

Since Specialization
Citations

This map shows the geographic impact of Yuichi Nozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Nozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Nozaki more than expected).

Fields of papers citing papers by Yuichi Nozaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Nozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Nozaki. The network helps show where Yuichi Nozaki may publish in the future.

Co-authorship network of co-authors of Yuichi Nozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Nozaki. A scholar is included among the top collaborators of Yuichi Nozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Nozaki. Yuichi Nozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sumida, Yoshio, Masashi Yoneda, Katsutoshi Tokushige, et al.. (2021). FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic. Life. 11(2). 143–143. 39 indexed citations
2.
Nozaki, Yuichi, Max C. Petersen, Dongyan Zhang, et al.. (2020). Metabolic control analysis of hepatic glycogen synthesis in vivo. Proceedings of the National Academy of Sciences. 117(14). 8166–8176. 64 indexed citations
3.
Sumida, Yoshio, Masashi Yoneda, Katsutoshi Tokushige, et al.. (2020). Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 21(6). 1907–1907. 50 indexed citations
4.
Perry, Rachel J., Dongyan Zhang, Mateus T. Guerra, et al.. (2020). Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis. Nature. 579(7798). 279–283. 124 indexed citations
5.
Ogawa, Yuji, Kento Imajo, Masato Yoneda, et al.. (2013). Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis. PLoS ONE. 8(6). e65211–e65211. 41 indexed citations
6.
Imajo, Kento, Koji Fujita, Masato Yoneda, et al.. (2012). Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling. Cell Metabolism. 16(1). 44–54. 283 indexed citations
7.
Yoneda, Masato, Koji Fujita, Yuichi Nozaki, et al.. (2010). Efficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: An open‐label, pilot study. Hepatology Research. 40(6). 566–573. 110 indexed citations
8.
Hosono, Kunihiro, Hiroki Endo, Hirokazu Takahashi, et al.. (2010). Metformin suppresses azoxymethane‐induced colorectal aberrant crypt foci by activating AMP‐activated protein kinase. Molecular Carcinogenesis. 49(7). 662–671. 151 indexed citations
9.
Mawatari, Hironori, Masato Yoneda, Koji Fujita, et al.. (2010). Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b. Journal of Viral Hepatitis. 17(12). 859–865. 1 indexed citations
10.
Yoneda, Masato, Kaori Suzuki, Shingo Kato, et al.. (2010). Nonalcoholic Fatty Liver Disease: US-based Acoustic Radiation Force Impulse Elastography. Radiology. 256(2). 640–647. 286 indexed citations
11.
Iida, Hiroshi, Masahiko Inamori, Yuichi Nozaki, et al.. (2009). Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values. BMC Gastroenterology. 9(1). 52–52. 6 indexed citations
12.
Endo, Hideaki, Kunihiro Hosono, Toshio Fujisawa, et al.. (2009). Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions. Gut. 58(12). 1637–1643. 38 indexed citations
13.
Nozaki, Yuichi, Koji Fujita, Masato Yoneda, et al.. (2009). Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease. Journal of Hepatology. 51(3). 548–556. 73 indexed citations
14.
Fujita, Koji, Yuichi Nozaki, Koichiro Wada, et al.. (2008). Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. Gut. 57(11). 1583–1591. 106 indexed citations
15.
Yoneda, Masato, Takashi Uchiyama, Shingo Kato, et al.. (2008). Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH). BMC Gastroenterology. 8(1). 53–53. 72 indexed citations
16.
Tomimoto, Ayako, Koichiro Wada, Toshio Fujisawa, et al.. (2007). 5-Aminosalicylic Acid Given in the Remission Stage of Colitis Suppresses Colitis-Associated Cancer in a Mouse Colitis Model. Clinical Cancer Research. 13(21). 6527–6531. 36 indexed citations
17.
Yoneda, Masato, Hiroki Endo, Yuichi Nozaki, et al.. (2007). Life Style-Related Diseases of the Digestive System: Gene Expression in Nonalcoholic Steatohepatitis Patients and Treatment Strategies. Journal of Pharmacological Sciences. 105(2). 151–156. 15 indexed citations
18.
Fujita, Koji, Masato Yoneda, Koichiro Wada, et al.. (2007). Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats. Digestive Diseases and Sciences. 52(12). 3455–3464. 64 indexed citations
19.
Yoneda, Masato, Tomoyuki Iwasaki, Koji Fujita, et al.. (2007). Hypoadiponectinemia Plays a Crucial Role in the Development of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus Independent of Visceral Adipose Tissue. Alcoholism Clinical and Experimental Research. 31(s1). S15–21. 35 indexed citations
20.
Yoneda, Minoru, Tatsunori Ikeda, Koji Fujita, et al.. (2007). Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. Journal of Viral Hepatitis. 14(9). 600–607. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Narci Teoh Breakdown of academic impact, for papers by Marica Meroni Breakdown of academic impact, for papers by Masafumi Ono Breakdown of academic impact, for papers by Roberto Torella Breakdown of academic impact, for papers by Lihua Zhu Breakdown of academic impact, for papers by Janki Patel Breakdown of academic impact, for papers by Chandrashekhar R. Gandhi Breakdown of academic impact, for papers by Ting Qian Breakdown of academic impact, for papers by Karim Gariani Breakdown of academic impact, for papers by Hiroki Endo
Rankless by CCL
2026